Biomarin Pharmaceutical (BMRN) Enterprise Value (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted Enterprise Value of -$2.2 billion for Q1 2026, down 42.41% on a QoQ basis from -$1.6 billion in Q4 2025, and down 74.67% year-over-year from -$8.8 billion in Q1 2025.
Biomarin Pharmaceutical (BMRN) Enterprise Value (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical's Enterprise Value history runs 18 years deep, the most recent figure standing at -$2.2 billion for Q1 2026.
- Quarterly Enterprise Value fell 74.67% year-over-year to -$2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 billion (down 74.67% YoY) and the FY2025 annual result came in at -$1.6 billion, down 37.17% from the prior year.
- Enterprise Value was -$2.2 billion for Q1 2026 at Biomarin Pharmaceutical, down from -$1.6 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$930.4 million in Q3 2024 and bottomed at -$2.2 billion in Q1 2026.
- A 5-year average of -$1.3 billion and a median of -$1.2 billion in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value rose 17.36% — and 2026, when it tumbled 74.67%.
- Biomarin Pharmaceutical's Enterprise Value stood at -$1.3 billion in 2022, then advanced by 16.86% to -$1.1 billion in 2023, then fell by 5.95% to -$1.1 billion in 2024, then tumbled by 37.17% to -$1.6 billion in 2025, then tumbled by 42.41% to -$2.2 billion in 2026.
- Business Quant data shows BMRN's Enterprise Value at -$2.2 billion in Q1 2026, -$1.6 billion in Q4 2025, and -$1.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | -2.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.22 Bn |
| Dec 31, 2025 | -1.56 Bn |
| Sep 30, 2025 | -1.48 Bn |
| Jun 30, 2025 | -1.43 Bn |
| Mar 31, 2025 | -1.27 Bn |
| Dec 31, 2024 | -1.14 Bn |
| Sep 30, 2024 | -930.44 Mn |
| Jun 30, 2024 | -1.22 Bn |
| Mar 31, 2024 | -1.05 Bn |
| Dec 31, 2023 | -1.07 Bn |
| Sep 30, 2023 | -1.13 Bn |
| Jun 30, 2023 | -1.17 Bn |
| Mar 31, 2023 | -1.15 Bn |
| Dec 31, 2022 | -1.29 Bn |
| Sep 30, 2022 | -1.27 Bn |
| Jun 30, 2022 | -1.11 Bn |
| Mar 31, 2022 | -1.06 Bn |
| Dec 31, 2021 | -1.01 Bn |
| Sep 30, 2021 | -1.08 Bn |
| Jun 30, 2021 | -1.12 Bn |